These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9610768)

  • 1. A 3-basepair deletion in repeat 1 of the LDL receptor promoter reduces transcriptional activity in a South African Pedi.
    Peeters AV; Kotze MJ; Scholtz CL; De Waal LF; Rubinsztein DC; Coetzee GA; Zuliani G; Streiff R; Liu J; van der Westhuyzen DR
    J Lipid Res; 1998 May; 39(5):1021-4. PubMed ID: 9610768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation -59c-->t in repeat 2 of the LDL receptor promoter: reduction in transcriptional activity and possible allelic interaction in a South African family with familial hypercholesterolaemia.
    Scholtz CL; Peeters AV; Hoogendijk CF; Thiart R; de Villiers JN; Hillermann R; Liu J; Marais AD; Kotze MJ
    Hum Mol Genet; 1999 Oct; 8(11):2025-30. PubMed ID: 10484771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.
    Thiart R; Scholtz CL; Vergotine J; Hoogendijk CF; de Villiers JN; Nissen H; Brusgaard K; Gaffney D; Hoffs MS; Vermaak WJ; Kotze MJ
    J Med Genet; 2000 Jul; 37(7):514-9. PubMed ID: 10882754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation (-49C>T) in the promoter of the low density lipoprotein receptor gene associated with familial hypercholesterolemia.
    Mozas P; Galetto R; Albajar M; Ros E; Pocoví M; Rodríguez-Rey JC
    J Lipid Res; 2002 Jan; 43(1):13-8. PubMed ID: 11792717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH).
    Sun XM; Neuwirth C; Wade DP; Knight BL; Soutar AK
    Hum Mol Genet; 1995 Nov; 4(11):2125-9. PubMed ID: 8589690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.
    Koivisto UM; Palvimo JJ; Jänne OA; Kontula K
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10526-30. PubMed ID: 7937987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia.
    Dedoussis GV; Pitsavos C; Kelberman D; Skoumas J; Prassa ME; Choumerianou DM; Stefanadis C; Humphries SE; Toutouzas P
    Clin Genet; 2003 Nov; 64(5):414-9. PubMed ID: 14616764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional mutation in the LDLR promoter (-139C>G) in a patient with familial hypercholesterolemia.
    Smith AJ; Ahmed F; Nair D; Whittall R; Wang D; Taylor A; Norbury G; Humphries SE
    Eur J Hum Genet; 2007 Nov; 15(11):1186-9. PubMed ID: 17625505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New promoter mutations in the low-density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: molecular and functional analysis.
    Francová H; Trbusek M; Zapletalová P; Kuhrová V
    J Inherit Metab Dis; 2004; 27(4):523-8. PubMed ID: 15303010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function.
    Natesampillai S; Fernandez-Zapico ME; Urrutia R; Veldhuis JD
    J Biol Chem; 2006 Feb; 281(6):3040-7. PubMed ID: 16303770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression.
    Li C; Briggs MR; Ahlborn TE; Kraemer FB; Liu J
    Endocrinology; 2001 Apr; 142(4):1546-53. PubMed ID: 11250935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells.
    Sekar N; Veldhuis JD
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E128-35. PubMed ID: 14998783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.
    Snozek CL; Lagerstedt SA; Khoo TK; Rubenfire M; Isley WL; Train LJ; Baudhuin LM
    Eur J Hum Genet; 2009 Jan; 17(1):85-90. PubMed ID: 18648394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent LDL-receptor mutation causes familial hypercholesterolaemia in South African coloureds and Afrikaners.
    Kotze MJ; Langenhoven E; Theart L; Loubser O; Micklem A; Oosthuizen CJ
    S Afr Med J; 1995 May; 85(5):357-61. PubMed ID: 7638684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel point mutations causing receptor-negative familial hypercholesterolemia in a South African Indian homozygote.
    Langenhoven E; Warnich L; Thiart R; Rubinsztein DC; van der Westhuyzen DR; Marais AD; Kotze MJ
    Atherosclerosis; 1996 Aug; 125(1):111-9. PubMed ID: 8831933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.
    Hoogendijk CF; Scholtz CL; Pimstone SM; Ehrenborg E; Kastelein JJ; Defesche JC; Thiart R; du Plessis L; de Villiers JN; Zaahl MG; Delport R; Rubinsztein DC; Raffel LJ; Grim CE; Mediene-Benchekor S; Amouyel P; Brousseau T; Steyn K; Lombard CJ; Hayden MR; Kotze MJ
    Mol Cell Probes; 2003 Aug; 17(4):175-81. PubMed ID: 12944120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia (FH Siracusa and FH Reggio Emilia).
    Garuti R; Lelli N; Barozzini M; Tiozzo R; Ghisellini M; Simone ML; Li Volti S; Garozzo R; Mollica F; Vergoni W; Bertolini S; Calandra S
    Atherosclerosis; 1996 Mar; 121(1):105-17. PubMed ID: 8678915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
    Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of LDLR promoter and 5' UTR mutations in subjects with clinical diagnosis of familial hypercholesterolemia.
    De Castro-Orós I; Pampín S; Bolado-Carrancio A; De Cubas A; Palacios L; Plana N; Puzo J; Martorell E; Stef M; Masana L; Civeira F; Rodríguez-Rey JC; Pocoví M
    Hum Mutat; 2011 Aug; 32(8):868-72. PubMed ID: 21538688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.